Response-shift effects in neuromyelitis optica spectrum disorder: estimating response-shift-adjusted scores using equating
Open Access
- 5 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Quality of Life Research
- Vol. 30 (5), 1283-1292
- https://doi.org/10.1007/s11136-020-02727-8
Abstract
Background In our companion paper, random intercept models (RIMs) investigated response-shift effects in a clinical trial comparing Eculizumab to Placebo for people with neuromyelitis optica spectrum disorder (NMOSD). RIMs predicted Global Health using the EQ-5D Visual Analogue Scale item (VAS) to encompass broad criteria that people might consider. The SF36™v2 mental and physical component scores (MCS and PCS) helped us detect response shift in VAS. Here, we sought to “back-translate” the VAS into the MCS/PCS scores that would have been observed if response shift had not been present. Methods This secondary analysis utilized NMOSD clinical trial data evaluating the impact of Eculizumab in preventing relapses (n = 143). Analyses began by equating raw scores from the VAS, MCS, and PCS, and computing scores that removed response-shift effects. Correlation analysis and descriptive displays provided a more comprehensive examination of response-shift effects. Results MCS and PCS crosswalks with VAS equated the scores that include and exclude response-shift effects. These two sets of scores had low shared variance for MCS for both groups, suggesting that corresponding mental health constructs were substantially different. The shared variance contrast for physical health was distinct only for the Placebo group. The larger MCS response-shift effects were found at end of study for Placebo only and were more prominent at extremes of the MCS score distribution. Conclusions Our results reveal notable treatment group differences in MCS but not PCS response shifts, which can explain null results detected in previous work. The method introduced herein provides a way to provide further information about response-shift effects in clinical trial data.Keywords
This publication has 25 references indexed in Scilit:
- The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and InterpretationArchives of Physical Medicine and Rehabilitation, 2012
- Response shift: a brief overview and proposed research prioritiesQuality of Life Research, 2009
- The clinical significance of adaptation to changing health: A meta-analysis of response shiftQuality of Life Research, 2006
- Computerized adaptive testing of diabetes impact: A feasibility study of Hispanics and non-Hispanics in an active clinic populationQuality of Life Research, 2006
- Creating a Crosswalk to Estimate AIDS Clinical Trials Group Quality of Life Scores in a Nationally Representative Sample of Persons in Care for HIV in the United StatesHIV Research & Clinical Practice, 2005
- Integrating response shift into health-related quality of life research: a theoretical modelSocial Science & Medicine (1982), 1999
- Clinical understanding and clinical implications of response shiftSocial Science & Medicine (1982), 1999
- Differences in 4-Year Health Outcomes for Elderly and Poor, Chronically III Patients Treated in HMO and Fee-for-Service SystemsJAMA, 1996
- A power primer.Psychological Bulletin, 1992